Literature DB >> 400711

A specific radioimmunoassay for human beta-lipotropin.

W J Jeffcoate, L H Rees, P J Lowry, G M Besser.   

Abstract

A homologous RIA for human beta-lipotropin (beta hLPH) has been developed. At a final dilution of 1:24,000, the antiserum employed shows cross-reaction with beta hLPH but none with human beta-MSH (beta hMSH), and it is concluded that the antigenic determinant lies within the N-terminal 1-36 region of beta hLPH. With extraction of 3-ml plasma samples, the assay is sufficiently sensitive to measure circulating beta hLPH levels in normal individuals at 0900 h (25-200 pg/ml). There is a circadian variation with levels falling to (less than 20-80 pg/ml) at 2300 h. beta hLPH levels rise after metyrapone and after insulin-induced hypoglycemia, and fall after administration of dexamethasone. In patients with a variety of diseases of the pituitary-adrenal axis, levels of beta hLPH follow immunoreactive ACTH levels, although the two are not always secreted on a 1:1 molar basis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 400711     DOI: 10.1210/jcem-47-1-160

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Naloxone in treatment of circulatory shock resistant to conventional therapy.

Authors:  B Allolio; H Fischer; D Kaulen; U Deuss; W Winkelmann
Journal:  Klin Wochenschr       Date:  1987-03-02

2.  RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day.

Authors:  R C Gaillard; A Riondel; A F Muller; W Herrmann; E E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

3.  Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis.

Authors:  X Y Bertagna; W J Stone; W E Nicholson; C D Mount; D N Orth
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

4.  Increased central immunoreactive beta-endorphin content in patients with Wernicke-Korsakoff syndrome and in alcoholics.

Authors:  J A Summers; P T Pullan; J J Kril; C G Harper
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.